Healthcare Providers and Services
Company Overview of Vantage Oncology, LLC
Vantage Oncology, LLC owns and operates cancer treatment facilities. It offers surgeon consultation services in the areas of oncology surgical specialties, such as breast cancer, prostate, bladder and kidney cancers, head and neck cancer, neurosurgery, thoracic surgery, and colorectal and gynecological surgery; and surgeries to confirm that a patient has cancer, determine the stage of cancer, remove the primary tumor, and relieve cancer-related symptoms. The company also offers medical oncologist consultation services, such as chemotherapy, hormonal therapy, and immunotherapy; and integrated treatment programs that include surgical removal of the tumor, radiation therapy, chemotherapy, and o...
1500 Rosecrans Avenue
Manhattan Beach, CA 90266
Founded in 2002
Key Executives for Vantage Oncology, LLC
Co-Founder, Chairman of The Board and Chief Executive Officer
Co-Founder, Chief Medical Officer and Director
President of Vantage Cancer Care Network and Chief Clinical Officer of Vantage Cancer Care Network
Compensation as of Fiscal Year 2017.
Vantage Oncology, LLC Key Developments
Vantage Oncology, LLC and Vantage Oncology Finance Co. Announce Preliminary Results of Tender Offer for 9.500% Senior Secured Notes Due 2017
Mar 29 16
On March 11, 2016, Vantage Oncology, LLC and Vantage Oncology Finance Co. commenced a tender offer and a consent solicitation with respect to all of the Issuers' $300.0 million of outstanding 9.500% Senior Secured Notes due 2017, pursuant to the Offer to Purchase and Consent Solicitation Statement dated March 11, 2016. On March 28, 2016, holders of $215,714,000 aggregate principal amount of Notes (representing approximately 72% of the outstanding Notes) (the "Early Tendered Notes") had tendered their Notes into the Offer and given their consents to the "Proposed Amendments" in the Consent Solicitation. As a result, the Requisite Consents for the elimination of substantially all of the restrictive covenants (and certain events of default) in the Indenture governing the Notes and the release of all of the collateral securing the Notes have been received. The Issuers expect to enter into the Supplemental Indenture to such amendments and such release of collateral promptly. The Issuers expect to accept for payment and settle the Early Tendered Notes on April 1, 2016, which is the expected completion date for the acquisition of Vantage Oncology Holdings, LLC, the Issuers' parent, by McKesson Corporation pursuant to the previously announced acquisition agreement. Wells Fargo Bank, National Association is acting as Tender Agent for the Offer.
UC San Diego Health and Vantage Oncology Announce Cancer Care Collaboration
Mar 7 16
UC San Diego Health and Vantage Oncology are collaborating to provide comprehensive cancer care services to patients in Imperial Valley. Through a joint venture, UC San Diego Health and Vantage will operate Imperial Valley Radiation Oncology. Patients will have access to advanced radiation technologies as well as clinical trial interventions and specialty care consultations with UC San Diego Health and Moores Cancer Center. UC San Diego Health and Vantage share the same goals of delivering high quality, personalized cancer care. Vantage Oncology develops and operates radiation oncology centers of excellence throughout the United States with the mission of providing exceptional care in a community setting.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|